Psychopharmacology of anxiety-Reference-Cited by-同舟云学术

Psychopharmacology of anxiety

Published:2007-04 Issue:4 Volume:6 Page:143-148
ISSN:1476-1793
Container-title:Psychiatry
language:en
Short-container-title:Psychiatry

Author:

Nash Jon,Nutt David

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Phychiatric Mental Health

Reference26 articles.

1. The unhappy saga of happy pills;Nutt;J Psychopharmacol,2003

2. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology;Baldwin;J Psychopharmacol,2005

3. Anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. Clinical Guideline 23;National Institute for Clinical Excellence,2004

4. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders;Bandelow;World J Biol Psychiatry,2002

5. Comorbidity patterns in routine psychiatric practice: is there evidence of underdetection and underdiagnosis?;Wilk;Compr Psychiatry,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A psychometric evaluation of the 16-item PHQ-ADS concomitant anxiety and depression scale in the UK biobank using item response theory;Journal of Affective Disorders;2024-02

2. Zebrafish as a Useful Tool in the Research of Natural Products With Potential Anxiolytic Effects;Frontiers in Behavioral Neuroscience;2022-01-12

3. Functional neuroanatomy in panic disorder: Status quo of the research;World Journal of Psychiatry;2017

4. Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats;Behavioural Brain Research;2015-03

5. Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids;Bioanalysis;2009-08